AKER
Akers Biosciences, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
Market Cap: 1.67 Million
Primary Exchange: NASDAQ
Website: http://www.akersbio.com
Shares Outstanding: 523 Thousand
Float: 479 Thousand
Dividend: (%)
Beta: 0.899760651625073
Sector: Health Technology
Industry: Medical Specialties
Ethical Flags
Longest drawdown: 1995 trading days
From: 2013-10-21 To: 2019-11-22
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|